Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

WhatSAP - 2B4 sends mixed messages in the absence of SAP.

Watzl C, Claus M.

Eur J Immunol. 2014 May;44(5):1281-4. doi: 10.1002/eji.201444562.

2.

XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.

Meazza R, Tuberosa C, Cetica V, Falco M, Loiacono F, Parolini S, Micalizzi C, Moretta A, Mingari MC, Moretta L, Bottino C, Aricò M, Pende D.

Eur J Immunol. 2014 May;44(5):1526-34. doi: 10.1002/eji.201344312.

3.

Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis.

Meazza R, Tuberosa C, Cetica V, Falco M, Parolini S, Grieve S, Griffiths GM, Sieni E, Marcenaro S, Micalizzi C, Montin D, Fagioli F, Moretta A, Mingari MC, Moretta L, Notarangelo LD, Bottino C, Aricò M, Pende D.

J Allergy Clin Immunol. 2014 Dec;134(6):1381-1387.e7. doi: 10.1016/j.jaci.2014.04.043.

PMID:
24985396
4.
5.

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.

Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R, Ochs HD, Wolf H, Bonnefoy JY, Biassoni R, Moretta L, Notarangelo LD, Moretta A.

J Exp Med. 2000 Aug 7;192(3):337-46.

7.

2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.

Nakajima H, Colonna M.

Hum Immunol. 2000 Jan;61(1):39-43. Review.

PMID:
10658976
8.

Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.

Chen R, Relouzat F, Roncagalli R, Aoukaty A, Tan R, Latour S, Veillette A.

Mol Cell Biol. 2004 Jun;24(12):5144-56.

9.

Defective NK cell activation in X-linked lymphoproliferative disease.

Benoit L, Wang X, Pabst HF, Dutz J, Tan R.

J Immunol. 2000 Oct 1;165(7):3549-53.

10.

Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.

Sayós J, Nguyen KB, Wu C, Stepp SE, Howie D, Schatzle JD, Kumar V, Biron CA, Terhorst C.

Int Immunol. 2000 Dec;12(12):1749-57.

11.

Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).

Eissmann P, Beauchamp L, Wooters J, Tilton JC, Long EO, Watzl C.

Blood. 2005 Jun 15;105(12):4722-9.

12.

NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice.

Lee JE, Lim SA, Kim TJ, Kim K, Ng J, Kim YH, Jang IJ, Oh SB, Lee JC, Yee C, Kumar V, Lee KM.

Eur J Immunol. 2014 Jun;44(6):1802-13. doi: 10.1002/eji.201343724.

13.

NK cell regulation by SLAM family receptors and SAP-related adapters.

Veillette A.

Immunol Rev. 2006 Dec;214:22-34. Review.

PMID:
17100873
14.

Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity.

Nakajima H, Cella M, Bouchon A, Grierson HL, Lewis J, Duckett CS, Cohen JI, Colonna M.

Eur J Immunol. 2000 Nov;30(11):3309-18.

15.

Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.

Ma CS, Nichols KE, Tangye SG.

Annu Rev Immunol. 2007;25:337-79. Review.

PMID:
17201683
16.

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L.

Annu Rev Immunol. 2001;19:197-223. Review.

PMID:
11244035
17.
18.

Of mice and men: different functions of the murine and human 2B4 (CD244) receptor on NK cells.

Vaidya SV, Mathew PA.

Immunol Lett. 2006 Jun 15;105(2):180-4. Review.

PMID:
16621032
19.

The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.

Mooney JM, Klem J, Wülfing C, Mijares LA, Schwartzberg PL, Bennett M, Schatzle JD.

J Immunol. 2004 Sep 15;173(6):3953-61.

20.

Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.

Roda-Navarro P, Mittelbrunn M, Ortega M, Howie D, Terhorst C, Sánchez-Madrid F, Fernández-Ruiz E.

J Immunol. 2004 Sep 15;173(6):3640-6.

Items per page

Supplemental Content

Support Center